Vaccination

FDA gives nod to RSV vaccine for people in their 50s

The U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness.

Health

Live long, stay healthy: Study reveals important health markers

In a recent study, the Leibniz Institute for Prevention Research and Epidemiology—BIPS has made significant progress in identifying health markers that are crucial for a long and healthy life. Led by Prof. Dr. Krasimira ...

page 2 from 40